2023
DOI: 10.1002/adma.202306469
|View full text |Cite
|
Sign up to set email alerts
|

Liquid Nanoparticles for Nanocatalytic Cancer Therapy

Ruizhi Hu,
Xiaoying Chen,
Zhifang Li
et al.

Abstract: Nanotechnology is revolutionizing cancer therapy, and catalyzes the emerging of ion‐involved cancer‐therapeutic modality, which unfortunately suffers from undesirable nanocarriers for efficient intracellular ion delivery. To radically extricate from this critical issue, the glutathione (GSH)‐responsive organosilica network was employed to lock the liquid drops at the nanoscale via a general bottom‐up strategy to achieve the systemic delivery of “ion drugs”. In this work, a sulfate radical generation donor (Na2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(3 citation statements)
references
References 52 publications
(21 reference statements)
0
3
0
Order By: Relevance
“…A delivery platform based on macrophage was developed to achieve targeted tumor drug delivery and controlled release [ 101 ]. Some burgeoning nanoplatforms can also stably deliver drugs to activate pyroptosis [ 102 ]. Precisely activating pyroptosis in the tumor site can effectively prevent damage to normal tissues caused by pyroptosis.…”
Section: Introductionmentioning
confidence: 99%
“…A delivery platform based on macrophage was developed to achieve targeted tumor drug delivery and controlled release [ 101 ]. Some burgeoning nanoplatforms can also stably deliver drugs to activate pyroptosis [ 102 ]. Precisely activating pyroptosis in the tumor site can effectively prevent damage to normal tissues caused by pyroptosis.…”
Section: Introductionmentioning
confidence: 99%
“…Enhancing the immunogenicity of breast cancer cells is crucial for immune recognition and response. Excitingly, the elevated levels of H 2 O 2 and Fe 2+ in the tumor ECM not only contribute to remodeling the stromal microenvironment of tumors but also have the potential to trigger ferroptosis, which can enhance the immune system’s recognition and response to breast cancer cells . However, the ability of Fe 2+ to induce ferroptosis and activate immune responses is limited due to its low catalytic efficiency in the Fenton reaction and the harsh catalytic conditions required. , Therefore, other strategies for enhancing the immune response triggered by Fe 2+ -mediated ferroptosis need to be explored.…”
Section: Introductionmentioning
confidence: 99%
“…The evolution of nano-drug delivery systems has emerged as a pivotal solution to confront the constraints of conventional cancer treatments. Stimulus-responsive nanomaterial-based delivery systems offer a promising avenue due to their temporal and spatial advantages. , This paradigmatic approach relies on exogenous stimulus-responsive nanocomponents and structural adaptations that enable the precise modulation of drug delivery and release upon exposure to external triggers like light, temperature variations, and magnetic fields. Boron nitride (BN) nanomaterials, possessing a hexagonal structure similar to that of graphene, have emerged as promising candidates with significant potential applications in drug delivery and cancer treatment in recent years. Functioning as drug delivery platforms, BN nanomaterials demonstrate high drug loading capacity, multifunctionality, and low toxicity, providing robust support for precise drug delivery and release. Through surface modification, pH-responsive controlled release of chemotherapeutic drugs can be achieved, enhancing therapeutic efficacy while minimizing side effects on normal tissues . Simultaneously, in boron neutron capture therapy (BNCT), BN nanomaterials serve as carriers for 10 B, releasing high-energy particles through boron neutron capture reactions for precise radiation therapy, offering potential advantages in deep tissue treatment. …”
Section: Introductionmentioning
confidence: 99%